221 – 230 of 307
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort
(
- Contribution to journal › Article
-
Mark
Intraneuronal A beta Accumulation, Amyloid Plaques, and Synapse Pathology in Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Critical role of intraneuronal A beta in Alzheimer's disease: Technical challenges in studying intracellular A beta
(
- Contribution to journal › Article
-
Mark
Evaluation of Plasma A beta as Predictor of Alzheimer's Disease in Older Individuals Without Dementia: A Population-Based Study
(
- Contribution to journal › Article
-
Mark
Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Leukocyte Telomere Length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's Disease: A pilot study
(
- Contribution to journal › Article
-
Mark
Amyloid-beta Oligomers in Cerebrospinal Fluid are Associated with Cognitive Decline in Patients with Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Altered CSF Orexin and α-Synuclein Levels in Dementia Patients.
(
- Contribution to journal › Article
- 2011
-
Mark
Long Term Outcome and Prediction Models of Cognition, Activities of Daily Living and Nursing Home Placement in Alzheimer’s Disease with Cholinesterase Inhibitor Treatment
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Regional Differences in Effects of APOE epsilon 4 on Cognitive Impairment in Non-Demented Subjects
(
- Contribution to journal › Article